Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 482 results for "drl"

DRL posts consolidated revenues of Rs 37.6 billion, showing se...

Gross profit margin were at 61.1 per cent Dr Reddy's Laboratories (DRL) announced its consolidated financial results for the quarter ended June 30, 2015 under International Financial Reporting Standards (IFRS). . The consolidated revenues were at ... Financial Express, 2 days ago
DRL net rises 14% on better sales in North America Financial Express, 3 days ago
DRL's net up 14% at Rs 626 crore; Russia a drag Business Standard, 3 days ago
Yourstory.in

Dr Reddy's Labs joins hands with US-based Purdue University for better medical research

The US-based Purdue University has signed a Memorandum of Understanding (MoU) with Dr Reddy's Laboratories Limited (DRL) to strengthen pharmaceutical research and development. According to a statement issued by the University, the intent of the MoU ...
 Yourstory.in2 days ago Dr Reddy's signs MoU with Purdue University for drug research  Hindu Business Line4 days ago Dr Reddy's ink pact with Purdue varsity for drug research  The Financial Chronicle4 days ago DRL ink pact with Purdue varsity for drug research  Financial Express4 days ago
[x]  
New Indian Express

Dr Reddy's Q1 Net Up 14 Percentage at Rs 626 cr

HYDERABAD:Aided by robust sales in North America, Europe and India, Dr Reddy's Laboratories Ltd (DRL) reported a 13.67 per cent rise in its consolidated net profit at Rs 625.65 crore for the quarter ended June, 2015 as against Rs 550.39 crore during ...
 New Indian Express2 days ago Dr Reddy's Labs net surges by 14% in Q1 to Rs. 626 cr  PharmaBiz3 days ago
Financial Express

DRL recalls some drugs

Pharma major Dr. Reddy's Laboratories has voluntarily started recalling some of its drugs used to treat seizure and hypertension from the US market. According to the enforcement report of the USFDA, for the week ended June 24, the company last ...
 The Hindu1 month ago DRL Recalls Select Drugs from US Mkt  New Indian Express1 month ago DRL recalls anti-seizure drugs from US market  Press Trust of India1 month ago DRL recalls anti-seizure, hypertension drugs from US market  The Financial Chronicle1 month ago
[x]  

Dr Reddy's Labs in focus after launching generic dementia treatment tablets in US

July 14, 2015 Last Updated at 08:33 IST Dr Reddy's Laboratories (DRL) announced after trading hours yesterday, 13 July 2015, that it launched Memantine hydrochloride tablets USP, 5 mg and 10 mg, a therapeutic equivalent version of NAMENDA tablets (mamentine ...
 Business Standard2 weeks ago Accumulate Dr Reddys Labs; target of Rs 3957: KRChoksey  Money Control2 months ago Dr Reddy's Labs gains after launching generic dementia treatment tablets in US  Capital Market2 weeks ago
Sify

Sensex down 69 points; Coal India, DRL trade higher

Amid alternate bouts of buying and selling in front line stocks, the market is trading weak, having faltered again after a modest recovery that very nearly lifted it back into positive territory. The mood is quite cautious this morning, with investors looking ...
 Sify2 weeks ago

DRL announces launch of memantine hydrochloride tablets, USP

It is a therapeutic equivalent generic version of NAMENDA (memantine HCl) tablets in the US market Dr Reddy's Laboratories has launched memantine hydrochloride tablets USP, 5 mg and 10 mg, a therapeutic equivalent generic version of NAMENDA ...
 Financial Express2 weeks ago

DRL unveils new corporate brand identity

The new identity speaks of Dr Reddy's constant endeavour to understand the unmet and under-met needs of patients, and the swift action to solve them Dr Reddy's Laboratories (DRL) announced the launch of its new visual identity and brand, that ...
 Financial Express1 month ago Dr Reddy's unveils new corporate brand identity  Financial Express1 week ago

DRL recalls two generic drugs in US

HYDERABAD: City-headquartered pharma giant Dr Reddy's Laboratories (DRL) has announced that it is voluntarily recalling two generic drugs, manufactured at its Bachupally facility, from the US market. According to the US Food and Drug Administration ...
 Times of India1 month ago
NDTV Profit

RIL, HDFC Bank, DRL in Barclays' global stock picks

Press Trust of India | New Delhi June 30, 2015 Last Updated at 21:22 IST Reliance Industries Ltd (RIL), HDFC Bank and Dr Reddy's Laboratories are the only three Indian firms to figure in Barclays' top 111 stock picks from across the world for 2015. In its ...
 Business Standard1 month ago Reliance Industries, HDFC Bank, DRL in Barclays' global stock picks  Economic Times1 month ago Reliance Industries, HDFC Bank, Dr Reddy's Lab in Barclays global stock picks  Financial Express1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less